Table 5. Adjusted cost difference of the total cost of care and cardiovascular-related cost by lipid goal attainments among 2686 patients with complete five-year follow-up.

		Total cost of care (HKD)			Cardiovascular-related cost (HKD)
	N	Adjusted Coefficient*	(95% Confidence Interval)	p-value	Adjusted Coefficient*	(95% Confidence Interval)	p-value
Endpoint LDL-C achieving the goal of 2.6 mmol/L	2686
1st year: At goal vs Not at goal	2686	6548.52	(−3441.94, 16538.97)	0.20	10495.13	(5846.36, 15143.89)	< 0.001
2nd year: At goal vs Not at goal	2686	1433.02	(−6835.65, 9701.69)	0.73	−1637.26	(−5892.56, 2618.05)	0.45
3rd year: At goal vs Not at goal	2686	1404.19	(−6251.35, 9059.74)	0.72	−7.59	(−3437.71, 3422.53)	1.00
4th year: At goal vs Not at goal	2686	−4251.30	(−11714.31, 3211.71)	0.26	−1776.81	(−5662.26, 2108.64)	0.37
5th year: At goal vs Not at goal	2686	−748.84	(−7558.02, 6060.34)	0.83	−1529.18	(−5146.36, 2088.00)	0.41
Endpoint LDL-C achieving the goal of 1.8 mmol/L	2686
1st year: At goal vs Not at goal	2686	12764.70	(1199.33, 24330.08)	0.03	8367.48	(1343.69, 15391.27)	0.02
2nd year: At goal vs Not at goal	2686	10694.72	(1936.13, 19453.32)	0.02	739.51	(−2118.36, 3597.39)	0.61
3rd year: At goal vs Not at goal	2686	4185.83	(−3570.15, 11941.81)	0.29	2323.03	(−1117.32, 5763.37)	0.19
4th year: At goal vs Not at goal	2686	−2747.02	(−9003.42, 3509.38)	0.39	−1263.53	(−4107.77, 1580.71)	0.38
5th year: At goal vs Not at goal	2686	367.42	(−6025.01, 6759.85)	0.91	21.21	(−2939.33, 2981.74)	0.99
Endpoint LDL-C achieving the goal of 2.0 mmol/L	2686
1st year: At goal vs Not at goal	2686	8031.90	(−2052.35, 18116.14)	0.12	7683.58	(1678.83, 13688.32)	0.01
2nd year: At goal vs Not at goal	2686	6080.24	(−1372.17, 13532.65)	0.11	−167.99	(−2973.12, 2637.14)	0.91
3rd year: At goal vs Not at goal	2686	1853.03	(−5091.22, 8797.29)	0.60	1056.23	(−1890.38, 4002.83)	0.48
4th year: At goal vs Not at goal	2686	−6025.85	(−11884.44, −167.25)	0.04	−2474.41	(−5301.74, 352.93)	0.09
5th year: At goal vs Not at goal	2686	−405.39	(−6530.61, 5719.83)	0.90	−1076.21	(−3926.35, 1773.94)	0.46
Endpoint LDL-C achieving the reduction of 50%	2412
1st year: At goal vs Not at goal	2412	16472.69	(−2613.22, 35558.59)	0.09	10607.64	(297.47, 20917.80)	0.04
2nd year: At goal vs Not at goal	2412	−3062.50	(−11721.47, 5596.48)	0.49	−1222.43	(−4448.06, 2003.20)	0.46
3rd year: At goal vs Not at goal	2412	−1969.65	(−13188.12, 9248.82)	0.73	−182.27	(−5121.42, 4756.89)	0.94
4th year: At goal vs Not at goal	2412	−4115.05	(−13228.67, 4998.58)	0.38	−2179.64	(−5794.71, 1435.42)	0.24
5th year: At goal vs Not at goal	2412	2065.28	(−10846.31, 14976.88)	0.75	−1675.69	(−5453.84, 2102.45)	0.38

MACE, major adverse cardiovascular events; LDL-C, low-density lipoprotein cholesterol; HKD, Hong Kong dollars; Ref, reference.

^*Adjusted for age, sex, diabetes, hypertension, and prior cardiovascular history